Friday, February 03, 2017 7:42:34 AM
properties Scenesse holds but this article underscores how likely the implant is to alleviate / cure MS and other neuro inflammatory diseases.
They even specify that they are indeed using Scenesse in the lab.
Dr. Wolgen is fully aware of this as per the AGM but we won't see Clinuvel pursue other indications than dermatology and UV-related disorders.
Licensing, however, seems more and more plausible.
http://stm.sciencemag.org/content/8/362/362ra146
VHAI - Vocodia Partners with Leading Political Super PACs to Revolutionize Fundraising Efforts • VHAI • Sep 19, 2024 11:48 AM
Dear Cashmere Group Holding Co. AKA Swifty Global Signs Binding Letter of Intent to be Acquired by Signing Day Sports • DRCR • Sep 19, 2024 10:26 AM
HealthLynked Launches Virtual Urgent Care Through Partnership with Lyric Health. • HLYK • Sep 19, 2024 8:00 AM
Element79 Gold Corp. Appoints Kevin Arias as Advisor to the Board of Directors, Strengthening Strategic Leadership • ELMGF • Sep 18, 2024 10:29 AM
Mawson Finland Limited Further Expands the Known Mineralized Zones at Rajapalot: Palokas step-out drills 7 metres @ 9.1 g/t gold & 706 ppm cobalt • MFL • Sep 17, 2024 9:02 AM
PickleJar Announces Integration With OptCulture to Deliver Holistic Fan Experiences at Venue Point of Sale • PKLE • Sep 17, 2024 8:00 AM